Your email has been successfully added to our mailing list.

×
0 -0.05 -0.05 -0.05 -0.0476428571428571 -0.05 -0.0357142857142857 -0.0464285714285715
Stock impact report

Medicenna Doses First Patient in MDNA11 Phase 1/2 ABILITY Study [Financial Post (Toronto, Ontario, Canada)]

Medicenna Therapeutics Corp. - Common Shares (MDNA)  More Company Research Source: Financial Post
PDF — Preliminary update on safety, PK/PD, and biomarker data expected by year-end 2021 — Preliminary efficacy readouts from study expected over the course of 2022 TORONTO and HOUSTON, Sept. 14, 2021 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or “the Company”) (NASDAQ: MDNA TSX: MDNA), a clinical stage immuno-oncology company, today announced the initiation of dosing of patients in the Phase 1/2 ABILITY ( A B eta-only IL I mmuno T herap Y ) study of MDNA11, the Company's selective, long-acting and novel IL-2 super-agonist. The study is designed to assess the safety, PK, PD, and anti-tumor activity of various doses of intravenously administered MDNA11 in patients with advanced solid tumors and includes an MDNA11 monotherapy arm, as well as a combination arm designed to evaluate MDNA11 with a checkpoint inhibitor. “Dosing the first patient with MDNA11 in the ABILITY study is a major step towards demonstrating MDNA11's potential in the clinic as a differentiated an [Read more]
Impact snapshot Event time: MDNA
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
MDNA alerts

from News Quantified
Opt-in for
MDNA alerts

from News Quantified